Physician profile
Veronica Ramsarat
NPI 1477000545
$4,198.31
in general payments reported to CMS, 2019-2025
17 companies · $15.45 in 2025
The $15.45 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $84.24 · 2021: $372 · 2022: $864 · 2023: $1,176 · 2024: $326 · 2025: $15.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,246.53 | 2019 | |
| Alcon Vision LLC | $1,160.23 | 2020-2025 | Rocklatan, Simbrinza, Eysuvis |
| Sun Pharmaceutical Industries INC. | $627.32 | 2022-2023 | Cequa, Xelpros |
| Carl Zeiss Meditec USA, INC. | $294.10 | 2023 | Visumax |
| Aerie Pharmaceuticals, INC. | $190.07 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $139.11 | 2023-2024 | Vyzulta, Miebo |
| Allergan, INC. | $124.44 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $103.83 | 2021-2022 | |
| Abbvie INC. | $73.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $53.73 | 2020-2022 | |
| Coopervision INC. | $50.02 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.85 | 2020-2021 | |
| Dompe US, INC. | $24.29 | 2023 | Oxervate |
| Horizon Therapeutics Plc | $22.43 | 2023 | Tepezza |
| Eyevance Pharmaceuticals LLC | $20.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $14.77 | 2019 | |
| Shire North American Group INC | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Ramsarat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.